264 related articles for article (PubMed ID: 36951564)
21. COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study.
Dziedzic A; Issa J; Hussain S; Tanasiewicz M; Wojtyczka R; Kubina R; Konwinska MD; Riad A
Front Public Health; 2022; 10():938067. PubMed ID: 35958845
[TBL] [Abstract][Full Text] [Related]
22. Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey.
Noh Y; Kim JH; Yoon D; Choe YJ; Choe SA; Jung J; Lee SW; Shin JY
Epidemiol Health; 2022; 44():e2022061. PubMed ID: 35914771
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex with men in mainland China: a cross-sectional survey.
Zheng W; Sun Y; Li H; Zhao H; Zhan Y; Gao Y; Hu Y; Li P; Lin YF; Chen H; Meng H; Yang C; Fang Q; Yuan J; Jiang Y; Liu S; Cai Y; Zou H
Hum Vaccin Immunother; 2021 Dec; 17(12):4971-4981. PubMed ID: 34890297
[TBL] [Abstract][Full Text] [Related]
24. The association between social media use and hesitancy toward COVID-19 vaccine booster shots in China: A web-based cross-sectional survey.
Wang R; Qin C; Du M; Liu Q; Tao L; Liu J
Hum Vaccin Immunother; 2022 Nov; 18(5):2065167. PubMed ID: 35671384
[TBL] [Abstract][Full Text] [Related]
25. Factors affecting hesitancy toward COVID-19 vaccine booster doses in Canada: a cross-national survey.
Leigh JP; FitzGerald EA; Moss SJ; Brundin-Mather R; Dodds A; Stelfox HT; Dubé È; Fiest KM; Halperin D; Ahmed SB; MacDonald SE; Straus SE; Manca T; Kamstra JN; Soo A; Longmore S; Kupsch S; Sept B; Halperin S
Can J Public Health; 2024 Feb; 115(1):26-39. PubMed ID: 37991692
[TBL] [Abstract][Full Text] [Related]
26. Egyptian hemodialysis patients' willingness to receive the COVID-19 vaccine booster dose: a multicenter survey.
Abdulaziz HMM; Saleh MA; Elrggal ME; Omar ME; Hawash SA; Attiya AMN; Salem KM; Sabry AA
J Nephrol; 2023 Jun; 36(5):1329-1340. PubMed ID: 36862285
[TBL] [Abstract][Full Text] [Related]
27. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021.
Ehde DM; Roberts MK; Humbert AT; Herring TE; Alschuler KN
Mult Scler Relat Disord; 2021 Sep; 54():103163. PubMed ID: 34325399
[TBL] [Abstract][Full Text] [Related]
28. Identifying conditions for a third dose intention of COVID-19 vaccination in college students: A fuzzy-set qualitative comparative analysis.
Gao W; Zhang Y; Yin G
Front Public Health; 2022; 10():932243. PubMed ID: 36033777
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with COVID-19 booster vaccine hesitancy: a nationwide, cross-sectional survey in Japan.
Takamatsu A; Honda H; Miwa T; Tabuchi T; Taniguchi K; Shibuya K; Tokuda Y
Public Health; 2023 Oct; 223():72-79. PubMed ID: 37619504
[TBL] [Abstract][Full Text] [Related]
30. A Systematic Review on Sociodemographic, Financial and Psychological Factors Associated with COVID-19 Vaccine Booster Hesitancy among Adult Population.
Ayyalasomayajula S; Dhawan A; Karattuthodi MS; Thorakkattil SA; Abdulsalim S; Elnaem MH; Sridhar S; Unnikrishnan MK
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992207
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with COVID-19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: a cross-sectional study.
Allen K; Lambert SB; Yuen A; Pourmarzi D
BMC Public Health; 2022 Nov; 22(1):2205. PubMed ID: 36443806
[TBL] [Abstract][Full Text] [Related]
32. Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China.
Tung TH; Lin XQ; Chen Y; Zhang MX; Zhu JS
Hum Vaccin Immunother; 2022 Nov; 18(6):2099210. PubMed ID: 35880816
[TBL] [Abstract][Full Text] [Related]
33. Willingness of people living with HIV to receive a second COVID-19 booster dose: a multicenter cross-sectional study in China.
Lan X; Su B; Liang S; Yu M; Qiao Y; Wang L; Song M; Wang Y; Xu J
Front Public Health; 2023; 11():1227277. PubMed ID: 37680268
[TBL] [Abstract][Full Text] [Related]
34. The psychological and behavioural correlates of COVID-19 vaccine hesitancy and resistance in Ireland and the UK.
Walsh JC; Comar M; Folan J; Williams S; Kola-Palmer S
Acta Psychol (Amst); 2022 May; 225():103550. PubMed ID: 35259642
[TBL] [Abstract][Full Text] [Related]
35. Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children Among Child Caregivers in China.
Qin C; Wang R; Tao L; Liu M; Liu J
Front Public Health; 2022; 10():834572. PubMed ID: 35372197
[TBL] [Abstract][Full Text] [Related]
36. How urban versus rural population relates to COVID-19 booster vaccine hesitancy: A propensity score matching design study.
Miao Y; Bai J; Shen Z; Li Y; Zhang W; Zhu D; Ren R; Zhang J; Guo D; Tarimo CS; Dong W; Liu R; Zhao Q; Hu J; Li M; Wei W
Hum Vaccin Immunother; 2024 Dec; 20(1):2297490. PubMed ID: 38214317
[TBL] [Abstract][Full Text] [Related]
37. Who is more likely to hesitate to accept COVID-19 vaccine: a cross-sectional survey in China.
Zhang P; Zhang Q; Guan H; Fan K; Bi X; Huang Y; Liang L; Khoso AR; Xu X; Ma Y; Hao Y; Wu Q
Expert Rev Vaccines; 2022 Mar; 21(3):397-406. PubMed ID: 34961405
[TBL] [Abstract][Full Text] [Related]
38. Direct and Indirect Associations of Media Use With COVID-19 Vaccine Hesitancy in South Korea: Cross-sectional Web-Based Survey.
Lee M; You M
J Med Internet Res; 2022 Jan; 24(1):e32329. PubMed ID: 34870605
[TBL] [Abstract][Full Text] [Related]
39. Willingness to accept a second COVID-19 vaccination booster dose among healthcare workers in Italy.
Della Polla G; Miraglia Del Giudice G; Folcarelli L; Napoli A; Angelillo IF;
Front Public Health; 2022; 10():1051035. PubMed ID: 36568799
[TBL] [Abstract][Full Text] [Related]
40. Perception and willingness toward various immunization routes for COVID-19 vaccines: a cross-sectional survey in China.
Wang H; Cui M; Li S; Wu F; Jiang S; Chen H; Yuan J; Sun C
Front Public Health; 2023; 11():1192709. PubMed ID: 37818300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
